Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 30, 2022 - Issue 6
Submit an article Journal homepage
96
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Treatment experience in a HIV-infected patient with Vogt–Koyanagi–Harada disease – a case report

Yu Chen Hua Department of Ophthalmology, Changhua Christian Hospital, Changhua City, Taiwan
, MD &
San Ni Chena Department of Ophthalmology, Changhua Christian Hospital, Changhua City, Taiwan;b Department of Ophthalmology, Yunlin Christian Hospital, Yunlin, Taiwan;c School of Medicine, Chung-Shan Medical University, Taichung, Taiwan;d Department of Optometry, Da-Yeh University, Changhua, TaiwanCorrespondence[email protected]
, MD
Pages 1536-1540 | Received 03 Jan 2021, Accepted 01 Mar 2021, Published online: 10 Jun 2021

References

  • Burkholder BM. Vogt–Koyanagi–Harada disease. Curr Opin Ophthalmol. 2015;26(6):506–511. doi:10.1097/ICU.0000000000000206.
  • Moorthy RS, Inomata H, Rao NA. Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol. 1995;39:265–292. doi:10.1016/S0039-6257(05)80105-5.
  • Viviane MS, Felipe TSS, Carlos EH, et al. Diagnosis and classification of Vogt–Koyanagi–Harada disease. Autoimmun Rev. 2014;13(4–5):550–555. doi:10.1016/j.autrev.2014.01.023.
  • Yen YF, Chuang PH, Jen IA, et al. Incidence of autoimmune diseases in a nationwide HIV/AIDS patient cohort in Taiwan, 2000–2012. Ann Rheum Dis. 2016;76(4):661–665. doi:10.1136/annrheumdis-2016-209815.
  • Priya D, Sudharshan S, Biswas J. Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus/acquired immunodeficiency disease syndrome patient. Indian J Ophthalmol. 2017 May;65(5):413–416. doi:10.4103/ijo.IJO_544_16.
  • Sugita S, Takase H, Kawaguchi T, et al. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27(2–3):87–95. doi:10.1007/s10792-006-9020-y.
  • Stahl D, Lacroix DS, Misra N. et al. Alterations of self-reactive antibody repertoires in HIV disease: an insight into the role of T cells in the selection of autoreactive B cells. Immunol Lett. 2005;99:198–208. doi:10.1016/j.imlet.2005.02.018.
  • Panayiotakopoulos GD, Aroni K, Kyriaki D. et al. Paucity of Sjogren-like syndrome in a cohort of HIV-1-positive patients in the HAART era. Part II. Rheumatology. 2003;42:1164–1167. doi:10.1093/rheumatology/keg316.
  • Tsiakalos A, Routsias JG, Kordossis T. et al. Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia. J Infect Dis. 2011;204:902–911. doi:10.1093/infdis/jir433.
  • Martinez V, Diemert MC, Braibant M. et al. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune ctivation. Clin Infect Dis. 2009;48:123–132. doi:10.1086/595013.
  • Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood. 2005;106:572–576. doi:10.1182/blood-2005-01-0243.
  • Marcelo ML, Viviane MS, Celso M. et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11:29. doi:10.1186/s13023-016-0412-4.
  • Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513. doi:10.1016/S0002-9394(00)00659-0.
  • Heo JW, Cho BJ, Goldstein DA. et al. Fluocinolone acetonide implant for Vogt-Koyanagi-Harada disease. Three-year outcomes of efficacy and safety. Retina. 2016;36:2124–2131. doi:10.1097/IAE.0000000000001094.
  • Ariane F, Laure C, Dorine M, et al. Single dexamethasone intravitreal implant in the treatment of noninfectious uveitis. J Ocul Pharmacol Ther. 2017;33(4):290–297. doi:10.1089/jop.2016.0139.
  • Dominika P, Vom Brocke GA, Sibylle W. et al. Dexamethasone inserts in noninfectious uveitis a single-center experience. Ophthalmology. 2018;125:1088–1099. doi:10.1016/j.ophtha.2017.12.038.
  • Maria EL, Donato R, Francesco C, et al. Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis. Clin Rheumatol. 2015 Jun;34(6):1145–1148. doi:10.1007/s10067-014-2623-1.
  • Lai T, Chan R, Chan C, Lam D. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond). 2009;23(3):543–548. doi:10.1038/eye.2008.89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.